As of January 2023, the X-waiver is no longer required to prescribe buprenorphine for opioid use disorder. Any references to the X-waiver no longer apply. The educational content on this site that offers CME meets the MATE Act requirements of 8 hours of training required for DEA certification.
The UCLA OASIS-TTA Program is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response SOR3 Grant to the California Department of Health Care Services (DHCS)
